Core Laboratories upgraded to Outperform from Market Perform at FBR Capital FBR Capital upgraded Core Laboratories on expectations the company's earnings growth should accelerate following its strong Q4 results. The firm raised its price target for shares to $150 from $110.
News For CLB From The Last 14 Days
Check below for free stories on CLB the last two weeks.